In this issue:
Decreased Aβ42 predicts dopamine-resistant gait progression in early PD
Reduced cognitive function in PD with OSA
Pyridostigmine bromide not better than fludrocortisone for orthostatic hypotension in PD
Cerebral glucose metabolism and cognition in new PD
Prevalence and clinical features of ICDs in PD
Risk factors for early PD psychosis
Impaired dual tasking in PD related to corticostriatal activity
MRI biomarker for diagnosing PD
Please login below to download this issue (PDF)